Biocon India

Rediff.com » News » Biocon India

News for Biocon India

News
Business

Bengaluru Faces Urban Breakdown

Bengaluru is at a critical juncture, where its economic model, reliant on attracting and retaining skilled professionals, is directly threatened by a measurable decline in urban quality of life,......

Biocon drug gets nod for use in moderate to severe COVID-19 patients

Biotechnology major Biocon on Saturday announced that its 'breakthrough drug', Itolizumab has received Drugs Controller General of India's (DCGI) approval for its use in moderate to......

Siddaramaiah Goes Backfoot On Local Quota Bill

Sources within the Congress, including those who have been members of the teams that drafted its 2019 and 2024 Lok Sabha poll manifestos, said the Karnataka government decision lacked any empirical......

Biz tycoons LN Mittal, Kiran Mazumdar Shaw among electoral bond buyers

Corporate donations worth thousands of crores to political parties through now-scrapped electoral bonds may have hit the headlines, but there were also 132 such bonds of just Rs 1,000 each bought......

Electoral Bonds: The Quid Pro Quo Factor

Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu. Illustration: Uttam Ghosh/Rediff.com The State Bank of India......

Biocon launches diabetes & obesity drugs in Netherlands

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the......

USFDA's new draft biosimilar rules to benefit Indian biotech cos

The US Food and Drug Administration’s (USFDA)’s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic......

Bengaluru Traffic Test Corporate Patience

'We do not need short-term measures but long-term ones. Companies seem to have given up on the infrastructure part. Long delays are fuelling more traffic crisis.' IMAGE: Potholes on Bengaluru......

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

India’s pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25......

SBI eyes Rs 25,000 crore via record QIP, sets floor at 2.5% discount

State Bank of India (SBI), the largest lender in the country, has launched a share sale to institutional investors to raise upto Rs 25,000 crore, the biggest qualified institutional placement (QIP)......

Biocon India

News for Biocon India

Bengaluru Faces Urban Breakdown

Biocon drug gets nod for use in moderate to severe COVID-19 patients

Siddaramaiah Goes Backfoot On Local Quota Bill

Biz tycoons LN Mittal, Kiran Mazumdar Shaw among electoral bond buyers

Electoral Bonds: The Quid Pro Quo Factor

Biocon launches diabetes & obesity drugs in Netherlands

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Bengaluru Traffic Test Corporate Patience

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

SBI eyes Rs 25,000 crore via record QIP, sets floor at 2.5% discount

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS